Spire Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744 Buy
+51
New +$492 ﹤0.01% 2175
2022
Q1
Sell
-50
Closed -$2K 2753
2021
Q4
$2K Buy
+50
New +$1.96K ﹤0.01% 2789
2021
Q3
Sell
-700
Closed -$32K 2624
2021
Q2
$32K Buy
700
+400
+133% +$17.7K ﹤0.01% 1668
2021
Q1
$14K Buy
+300
New +$15.6K ﹤0.01% 2302

Other funds holding NEO

Spire Wealth Management's NEO Position: Q2 2026 in Review

Spire Wealth Management opened a new position in NeoGenomics (NEO) in Q2 2026: 51 shares worth $744. The stake represents ﹤0.01% of the portfolio and ranks #2175 among its holdings. This is a return to the name: Spire Wealth Management previously reported a position in NEO as recently as Q4 2021.

Spire Wealth Management first reported a position in NEO in Q1 2021 and has held it in 4 quarters since. The position peaked at $32K in Q2 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Spire Wealth Management held 51 shares of NeoGenomics worth $744 as of Q2 2026.
  • NeoGenomics was a new Spire Wealth Management position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #2175 holding.
  • Spire Wealth Management first reported a position in NeoGenomics in Q1 2021 and has held it in 4 quarters since.
  • Spire Wealth Management's NeoGenomics position peaked at $32K in Q2 2021.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.